Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with no known effective therapy. It is often assumed, but has not been objectively evaluated, that pulmonary inflammation subsides as IPF progresses. The goal of this work was to assess changes in the degree of inflammatory cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Todd, Nevins W, Scheraga, Rachel G, Galvin, Jeffrey R, Iacono, Aldo T, Britt, E James, Luzina, Irina G, Burke, Allen P, Atamas, Sergei P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617818/
https://www.ncbi.nlm.nih.gov/pubmed/23576879
http://dx.doi.org/10.2147/JIR.S40673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617818/
https://www.ncbi.nlm.nih.gov/pubmed/23576879
http://dx.doi.org/10.2147/JIR.S40673

Ejemplares similares